-
+21 +1
'New chance at life': Man gets face, hands in rare surgery
Almost six months after a rare face and hands transplant, Joe DiMeo is relearning how to smile, blink, pinch and squeeze. The 22-year-old New Jersey resident had the operation last August, two years after being badly burned in a car crash.
-
+1 +1
What to Do if You Are a Victim of Medical Malpractice
Even though mistakes happen in every industry, medical mistakes can be deadly. They can jeopardize someone's entire life. Did you know that approximately 10% of the deaths are caused by medical malpractices? That's why it's important to detect it and prevent it on time. Even though medical mistakes aren’t always done on purpose, you need to recognise when you’re being mistreated. So, what can you do to save your own life and get justice after you’ve been a victim of medical malpractice? Here are 5 practical tips and steps to take if you ever find yourself in such a stressful situation.
-
+4 +1
Medical schools see surge in applicants, thanks to "Fauci effect"
Medical schools applications are surging, as the coronavirus outbreak prompts young people to reconsider health care professions. Applications are up 18% nationwide to medical school nationwide, compared to the same period last year, according to the Association of American Medical Colleges.
-
+21 +1
Covid blood test can predict patient survival chances
A blood test has been developed that can predict whether Covid patients will need intensive care – or are even likely to survive – shortly after they develop symptoms.
-
+20 +1
Japan’s 10-Year Cancer Survival Rate Rises to 58.3%
The 10-year survival rate for cancer, once regarded as an incurable disease, has steadily been improving in Japan and if the cancer can be detected early enough, this survival rate increases further.
-
+21 +1
New research could help millions who suffer from ‘ringing in the ears’
In the largest clinical trial of its kind, researchers show that combining sound and electrical stimulation of the tongue can significantly reduce tinnitus, commonly described as “ringing in the ears.” They also found that therapeutic effects can be sustained for up to 12 months post-treatment. The findings could potentially help millions of people since tinnitus affects about 10 to 15 percent of the population worldwide.
-
+14 +1
Why medics and the law clash with family in brain death cases – Sharon Kaufman
What happens when there are two competing definitions of death, confounding our understanding of the end of life? On 9 December 2013, Jahi McMath, a 13-year-old African-American girl living in Oakland, California, entered the hospital for a tonsillectomy, still one of the most common surgical procedures performed on children and often recommended for sleep apnoea, a condition she had been living with.
-
+13 +1
Even as the Economy Grew, More Children Lost Health Insurance
A new analysis shows that coverage levels fell for a third straight year. And that was before the pandemic struck. The share of children with health coverage in the United States fell for the third consecutive year in 2019, according to census data, after decades of increases. The decline occurred during a period of economic growth — before the coronavirus pandemic caused broad job losses that might have cost many more Americans their health insurance.
-
+19 +1
Crispr-Cas9: Two Women 'Genetic Scissor Doctors' Awarded With Nobel Prize
The recognized pioneers of controversial gene-editing tool "Crispr-Cas9" are recently awarded by this year's Nobel Prize in Chemistry. Scientists Emmanuelle Charpentier and Jennifer Doudna are two women researchers that are recently added to the list of Nobel Prize winners of the world. This tool has been controversial due to its past issues of allegedly altering the genes of two unborn twins in China to stop them from acquiring AIDS.
-
+13 +1
Rapid COVID-19 tests to be rolled out in poorer countries
The World Health Organization (WHO) said Monday that it has agreed to a plan to roll out 120 million rapid-diagnostic tests for the coronavirus. Along with its leading partners, WHO aims to help lower- and middle-income countries make up ground in a testing gap with richer countries.
-
+21 +1
As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts
For 32-year-old Hanna Lockman of Louisville, Kentucky, it all started March 12. She was at work when she suddenly felt a stabbing pain in her chest. “It just got worse and worse and worse, to the point I was crying from the pain,” she recalled in a recent interview. At 3 am, the pain sent her to the emergency department. “I had developed a dry cough, maybe a mild fever. I don’t remember.”
-
+22 +1
Researchers develop anti-bacterial graphene face masks
Face masks have become an important tool in fighting against the COVID-19 pandemic. However, improper use or disposal of masks may lead to "secondary transmission". A research team from City University of Hong Kong (CityU) has successfully produced graphene masks with an anti-bacterial efficiency of 80%, which can be enhanced to almost 100% with exposure to sunlight for around 10 minutes. Initial tests also showed very promising results in the deactivation of two species of coronaviruses. The graphene masks are easily produced at low cost, and can help to resolve the problems of sourcing raw materials and disposing of non-biodegradable masks.
-
+23 +1
This Hospital Cost $52 Million. It Treated 79 Virus Patients.
The Queens Hospital Center emergency department has a capacity of 60, but on its worst night of the coronavirus pandemic, more than 180 patients lay on stretchers in the observation bays and hallways. Alarms rang incessantly as exhausted doctors rushed from crisis to crisis. Less than four miles away, a temporary hospital opened the next morning, on April 10.
-
+11 +1
New drug targets for lethal brain cancer discovered
More than 200 genes with novel and known roles in glioblastoma – the most aggressive type of brain cancer – offer promising new drug targets. Researchers from the Wellcome Sanger Institute, Addenbrooke’s Hospital and their collaborators engineered a new mouse model to show for the first time how a mutation in the well-known cancer gene, EGFR initiates glioblastoma, and works with a selection from more than 200 other genes to drive the cancer.
-
+17 +1
Autonomous wayfinding device for visually impaired people unable to home a guide dog
For some, not having a service dog is a choice as they are content with navigating their surroundings using other methods, but for others it is not even an option due to prohibiting lifestyle reasons—such as allergies, expenses or house size.
-
+2 +1
Some ‘Inert’ Drug Ingredients May Be Biologically Active
Some supposedly inert ingredients in common drugs — such as dyes and preservatives — may potentially be biologically active and could lead to unanticipated side effects, according to a preliminary new study by researchers from the UC San Francisco School of Pharmacy and the Novartis Institutes for BioMedical Research (NIBR).
-
+16 +1
Telesurgery has arrived, thanks to 5G
Surgery can be intimidating and hard to access at the best of times, but sky-rocketing Covid-19 cases in the U.S. have made getting non-essential surgeries not only dangerous but in some states, like Texas, completely inaccessible. Physicians in Italy might just have a solution in the form of a socially distant, 5G enabled surgery.
-
+16 +1
Three people with inherited diseases successfully treated with CRISPR
Two people with beta thalassaemia and one with sickle cell disease no longer require blood transfusions, which are normally used to treat severe forms of these inherited diseases, after their bone marrow stem cells were gene-edited with CRISPR.
-
+22 +1
Breathalyzer to Detect COVID-19 in Seconds
Being able to tell, in a matter of seconds, whether someone is infected with the virus that causes COVID-19 would certainly help put a halt to the ongoing pandemic. Existing tests typically involve a deep nasal swab to obtain enough fluid sample, which has to be transferred to a laboratory machine for processing, with the results usually available many hours or even days after. There are five minute tests on the market, but those still require an expensive machine at each testing site.
-
+21 +1
Australians to receive potential coronavirus vaccine in southern hemisphere's first human trials
More than 100 people in Melbourne and Brisbane have signed up to be involved in the first human trials of a vaccine for COVID-19. Clinical research organisation Nucleus Network will be in charge of the early stages of testing the vaccine NVX-CoV2373, before the trial expands to Brisbane within a week.
Submit a link
Start a discussion